Paper41999538
Linking metabolism and metastasis: elevated α-hydroxybutyric acid in oral squamous cell carcinoma patients with lymph node metastasis.
Gu X and 5 others. Metabolomics, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Linking metabolism and metastasis: elevated α-hydroxybutyric acid in oral squamous cell carcinoma patients with lymph node metastasis. Papers, record 41999538. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999538
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Linking metabolism and metastasis: elevated α-hydroxybutyric acid in oral squamous cell carcinoma patients with lymph node metastasis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mouth Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Lymphatic Metastasis | Major topic |
| Hydroxybutyrates | Major topic |
| Humans | |
| Female | |
| Metabolomics | |
| Gas Chromatography-Mass Spectrometry | |
| Male | |
| Middle Aged | |
| Aged | |
| Metabolome |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,242,608 | Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. | Neoplasia | 2009 | https://conductscience.org/library/papers/19242608 | PubMed |
| 2 | 25,435,976 | Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats. | Oncol Lett | 2015 | https://conductscience.org/library/papers/25435976 | PubMed |
| 3 | 32,601,197 | Oral squamous cell carcinoma diagnosed from saliva metabolic profiling. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32601197 | PubMed |
| 4 | 31,898,477 | The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. | BMC Genomics | 2020 | https://conductscience.org/library/papers/31898477 | PubMed |
| 5 | 33,141,425 | Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison. | Pharmacol Rep | 2021 | https://conductscience.org/library/papers/33141425 | PubMed |
| 6 | 37,406,987 | Increased α-HB links colorectal cancer and diabetes by potentiating NF-κB signaling. | Mol Metab | 2023 | https://conductscience.org/library/papers/37406987 | PubMed |
| 7 | 39,059,359 | 100 years of the Warburg effect: A cancer metabolism endeavor. | Cell | 2024 | https://conductscience.org/library/papers/39059359 | PubMed |
| 8 | 34,940,595 | Which Role Plays 2-Hydroxybutyric Acid on Insulin Resistance? | Metabolites | 2021 | https://conductscience.org/library/papers/34940595 | PubMed |
| 9 | 38,355,833 | Web-based multi-omics integration using the Analyst software suite. | Nat Protoc | 2024 | https://conductscience.org/library/papers/38355833 | PubMed |
| 10 | 33,000,429 | Metabolic landscape of oral squamous cell carcinoma. | Metabolomics | 2020 | https://conductscience.org/library/papers/33000429 | PubMed |
| 11 | 33,982,817 | Metabolomics in cancer research and emerging applications in clinical oncology. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33982817 | PubMed |
| 12 | 37,729,870 | A blood-based metabolomic signature predictive of risk for pancreatic cancer. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37729870 | PubMed |
| 13 | 34,649,956 | Redox Regulation in Cancer Cells during Metastasis. | Cancer Discov | 2021 | https://conductscience.org/library/papers/34649956 | PubMed |
| 14 | 32,235,493 | Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma. | J Clin Med | 2020 | https://conductscience.org/library/papers/32235493 | PubMed |
| 15 | 26,965,202 | Emerging applications of metabolomics in drug discovery and precision medicine. | Nat Rev Drug Discov | 2016 | https://conductscience.org/library/papers/26965202 | PubMed |
| 16 | 25,037,503 | The pentose phosphate pathway and cancer. | Trends Biochem Sci | 2014 | https://conductscience.org/library/papers/25037503 | PubMed |
| 17 | 34,518,686 | A guide to machine learning for biologists. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/34518686 | PubMed |
| 18 | 30,282,895 | Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis. | Kobe J Med Sci | 2018 | https://conductscience.org/library/papers/30282895 | PubMed |
| 19 | 39,569,439 | Hypothalamic-Pituitary-Adrenal Axis Dysfunction in People With Cancer: A Systematic Review. | Cancer Med | 2024 | https://conductscience.org/library/papers/39569439 | PubMed |
| 20 | 36,858,045 | What is cancer metabolism? | Cell | 2023 | https://conductscience.org/library/papers/36858045 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41999538
GET https://conductscience.org/api/papers/v1/41999538/references?page=2